Eric Grogan Archives

New leaders named to Vanderbilt-Ingram research programs

Aug. 10, 2023—Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.

Event set to make lung cancer screening more accessible

Oct. 20, 2022—Vanderbilt University Medical Center is making the lung cancer screening more convenient with weekend appointments from 8 a.m. to noon on Saturday, Nov. 12, at Vanderbilt Health One Hundred Oaks

Members of the newly named MASLAB gathered for a portrait on the Medical Center Plaza. The early lung cancer detection research initiative was named in honor of the late Pierre Massion, MD.

Lung cancer detection program lands grant renewal

Sep. 15, 2022—The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.

Surgery risk model proves invaluable during pandemic

Oct. 29, 2020—When Gov. Bill Lee halted all elective, or scheduled rather than urgent, surgical procedures in Tennessee on March 19 in order to slow the spread of COVID-19 and conserve medical supplies and equipment, surgical and administrative leaders at Vanderbilt University Medical Center began seeking solid data to drive any future decision to safely restart these procedures.

Elizabeth “Betsy” Barbour and her late husband, Richard, created a fund to help support Vanderbilt’s lung transplant patient assistance fund.

Couple’s transplant journey continues by helping others

Jul. 25, 2019—Elizabeth “Betsy” Barbour and her late husband, Richard, created a fund to help support Vanderbilt’s lung transplant patient assistance fund.

The Vanderbilt team studying histoplasmosis includes (front row, from left, Heidi Chen, PhD, Melinda Aldrich, PhD, MPH, (back row, from left) Stephen Deppen, PhD, Eric Grogan, MD, MPH, and Jeffrey Blume, PhD.

Team explores fungal infection quandary in lung cancer screenings

Apr. 18, 2019—Serving a region that lies within the tobacco belt, clinicians at Vanderbilt Health face challenges distinguishing lung cancer from histoplasmosis, a fungal infection that creates cancer-mimicking lesions in the lungs.

Past and present members of the Vanderbilt Transplant Center, guests and patients attended a celebration of VUMC’s 500th lung transplant at the Student Life Center Feb. 5. Shown here are (back row, from left) Matthew Bacchetta, MD, MBA, MA; Ivan Robbins, MD; Eric Grogan, MD, MPH; and Eric Lambright, MD; (front row, from left) James Loyd, MD; Pam Smith; Erin Gillaspie, MD, MPH; Andy Bolden and Ciara Shaver, MD, PhD. Bolden is the recipient of the 500th lung transplant at Vanderbilt, and Smith, who was transplanted at Vanderbilt in 1990, is the longest-surviving single-lung transplant patient in the United States. Vanderbilt performed its first combined heart/lung transplant in 1987 and its first single-lung transplant in 1990.

Celebrating a transplant milestone

Feb. 14, 2019—Past and present members of the Vanderbilt Transplant Center, guests and patients attended a celebration of VUMC’s 500th lung transplant at the Student Life Center Feb. 5.

New robot expands options for thoracic surgery patients

Apr. 26, 2018—The thoracic surgery team at Vanderbilt University Medical Center recently added a new tool to its collection of minimally invasive techniques to provide patients the most advanced robotic-assisted surgical procedures.

Study finds accuracy of lung cancer imaging varies by region

Sep. 24, 2014—A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common.

Study finds obesity increases time in OR for lung surgery

Dec. 13, 2012—A new study led by Vanderbilt University Medical Center investigators found that obese patients undergoing surgery for lung cancer spent more time in the operating room, adding to the nation’s health care bill.

Lung nodule surgery not always “futile”

Dec. 7, 2011—Even when lung operations for suspected cancer resection results in a benign diagnosis, there still may be significant benefits to the procedure, new research suggests.